Northwestern University Department of Dermatology
Chicago, Illinois, 60611, United States
NCT Number: NCT01722916
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Early Phase 1
Chicago, Illinois, 60611, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 weeks
Northwestern University
Other
Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06644105
Drug Metabolism, Drug Safety
Chengdu, China
View Trial DetailsNCT01669824
Aspirin, Drug Safety
Multiple Locations, Germany
View Trial DetailsNCT01367873
Drug Safety
Fargo, North Dakota, United States
View Trial DetailsNCT01179854
Drug Safety, Normal Drug Tolerance
Barnaul, Russia
View Trial Details